SCHEMBL29936166

SCHEMBL29936166

CCc1nc(Cl)c2scc(C)c2n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.37
ADORA1 P30542 5/20 0.37
PDE4B Q07343 1/20 0.34
PDE7A Q13946 1/20 0.34
PDPK1 O15530 1/20 0.33
PRKCI P41743 5/20 0.33
TNKS O95271 1/20 0.33
PARP1 P09874 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDE5A O76074 1/20 0.32
ADORA2B P29275 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
MAPK1 P28482 1/20 0.31
KDM4E B2RXH2 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5579149 0.78 PDPK1 (0.37) PDE4BPDE7APDPK1PRKCITNKS
SCHEMBL358761 0.78 PDPK1 (0.37) PDE4BPDE7APDPK1PRKCITNKS
SCHEMBL20659863 0.72 ELANE (0.40) ADORA2AADORA1PDE5ALMNAHTT
SCHEMBL10264631 0.72 PDE4B (0.36) PDE4BPDE7APDPK1PRKCITNKS
SCHEMBL23498442 0.71 SMN1; SMN2 (0.35) ADORA2AADORA1PDPK1TNKSPARP1
SCHEMBL164692 0.71 MAPT (0.40) SMN1; SMN2MAPTTSHRMAPK1RXFP1
SCHEMBL29936201 0.70 PDE10A (0.50) PDE4BPDE7A
SCHEMBL23519900 0.70 PDE10A (0.50) PDE4BPDE7A
SCHEMBL4715461 0.68 ADORA2A (0.62) ADORA2AADORA1PDE4BADORA2BADORA3
SCHEMBL11315499 0.67 PDPK1 (0.37) PDE4BPDE7APDPK1PRKCITNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4073073-A1 THIENOPYRIMIDINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2022-10-19 EP disclosed